Back to dashboard
Medicare AdvantageCoverageMedium impact

The Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) System (Medtronic Inc.) for the treatment of life-threatening ventricular arrhythmias (Retroactively Effective To October 20, 2023)

Independence Blue Cross·Cardiology, Cardiothoracic Surgery, Critical Care·News & Announcements
Effective date
Oct 20, 2023
We identified it
Jun 19, 2026
Days to comply

Summary

Medtronic's Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) System has been added as a covered treatment option for life-threatening ventricular arrhythmias, retroactively effective to October 20, 2023. This policy clarifies coverage and billing requirements for this less-invasive ICD alternative.

Action Required

Action needed
Immediately: Billing team must review the full policy at the provided URL to identify specific CPT, HCPCS, and ICD-10 codes applicable to Aurora EV-ICD implantation and related procedures. Cardiology and cardiac surgery providers should update their systems to recognize this device as a covered option. Verify prior authorization requirements with the payer and update encounter forms and billing documentation templates accordingly. Claims for Aurora EV-ICD procedures submitted after October 20, 2023 should reference this policy if previously denied. Contact Medtronic and the payer for device-specific billing codes if not included in the full policy text.